CompletedPhase 2NCT00919113
Efficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
Studying Interstitial cystitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Watson Pharmaceuticals
- Principal Investigator
- Lawrence A Hill, PharmD, MBAWatson Laboratories, Inc.
- Intervention
- 2% sodium chondroitin sulfate(drug)
- Enrollment
- 98 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2009 – 2010
Study locations (20)
- Boulder, Colorado, United States
- Denver, Colorado, United States
- Farmington, Connecticut, United States
- Plantation, Florida, United States
- Wellington, Florida, United States
- Columbus, Georgia, United States
- Coeur d'Alene, Idaho, United States
- Evanston, Illinois, United States
- Melrose Park, Illinois, United States
- Royal Oak, Michigan, United States
- Las Vegas, Nevada, United States
- Englewood, New Jersey, United States
- Sewell, New Jersey, United States
- Woodlane, New Jersey, United States
- Albany, New York, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00919113 on ClinicalTrials.govOther trials for Interstitial cystitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT06752603A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial CystitisOno Pharmaceutical Co. Ltd
- RECRUITINGEARLY PHASE1NCT04734106Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial CystitisWake Forest University Health Sciences
- RECRUITINGNANCT06366269Acupuncture First for IC/BPSUniversity Hospitals Cleveland Medical Center
- RECRUITINGPHASE2NCT06394830Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Vaneltix Pharma, Inc.
- RECRUITINGNCT06729151Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain SyndromeWalter Reed National Military Medical Center
- RECRUITINGNCT06719232Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical InstillationJahn Ferenc South Pest Teaching Hospital
- RECRUITINGPHASE2, PHASE3NCT06096597Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder SyndromeDavid Sheyn
- RECRUITINGNANCT06299683Pain Type and Interstitial Cystitis/Bladder Pain Syndrome TreatmentVanderbilt University Medical Center